A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris

Completed · Phase 2 · Has a placebo group

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.

Key facts

Study ID

NCT00525499

Run by

AndroScience Corp

People needed

186

Starts

2007-08-01

Expected to finish

2008-07-01

Last updated by the study team

2011-11-23

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 12 years of age.
• Facial acne, with:
• 20 -100 inflammatory facial lesions 20 -100 noninflammatory facial lesions No more than 2 nodules/cysts on the face

You may not qualify if…

• Women who are pregnant or breastfeeding
• Skin diseases other than acne vulgaris
• Use of oral retinoids within 6 months of Baseline Visit
• Unwilling to discontinue all other treatments for facial acne
• Unwilling to avoid excessive swimming/sun exposure and use of cosmetics

Where it is running

• East Bay Dermatology Medical Group — Fremont, California, United States
• Therapeutics Clinical Research — San Diego, California, United States
• Northwest Clinical Trial — Boise, Idaho, United States
• TKL Research, Inc — Paramus, New Jersey, United States
• Academic Dermatology Associates — Albuquerque, New Mexico, United States
• Dermatology Associates — Knoxville, Tennessee, United States
• DermResearch, Inc — Austin, Texas, United States
• J&S Studies, Inc — Bryan, Texas, United States
• Dermatology Research Center, Inc — Salt Lake City, Utah, United States
• Education and Research Foundation — Lynchburg, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.